<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Prison-based harm reduction services are needed to address the dual" exact="substance use disorder" post="and infectious disease epidemics in US prisons OhringerAlison R.aohringer@med.miami.edua�?�EzerTamarbSerotaDavid"/>
 <result pre="harm reduction services are needed to address the dual substance" exact="use disorder" post="and infectious disease epidemics in US prisons OhringerAlison R.aohringer@med.miami.edua�?�EzerTamarbSerotaDavid"/>
 <result pre="are needed to address the dual substance use disorder and" exact="infectious disease" post="epidemics in US prisons OhringerAlison R.aohringer@med.miami.edua�?�EzerTamarbSerotaDavid P.a[a], [b], �?�Corresponding"/>
 <result pre="needed to address the dual substance use disorder and infectious" exact="disease" post="epidemics in US prisons OhringerAlison R.aohringer@med.miami.edua�?�EzerTamarbSerotaDavid P.a[a], [b], �?�Corresponding"/>
 <result pre="100,000 adults [1]. Incarcerated people have a high prevalence of" exact="chronic" post="medical conditions, including substance use disorder (SUD)—present in 65%"/>
 <result pre="people have a high prevalence of chronic medical conditions, including" exact="substance use disorder" post="(SUD)—present in 65% of people incarcerated in the US—and"/>
 <result pre="have a high prevalence of chronic medical conditions, including substance" exact="use disorder" post="(SUD)—present in 65% of people incarcerated in the US—and"/>
 <result pre="disorder (SUD)—present in 65% of people incarcerated in the US—and" exact="chronic" post="viral infections [2]. The prevalence of human immunodeficiency virus"/>
 <result pre="(SUD)—present in 65% of people incarcerated in the US—and chronic" exact="viral" post="infections [2]. The prevalence of human immunodeficiency virus (HIV)"/>
 <result pre="in 65% of people incarcerated in the US—and chronic viral" exact="infections" post="[2]. The prevalence of human immunodeficiency virus (HIV) among"/>
 <result pre="the US—and chronic viral infections [2]. The prevalence of human" exact="immunodeficiency" post="virus (HIV) among incarcerated people in the US is"/>
 <result pre="incarcerated [3]. Additionally, one-third of the 20,00,000+ incarcerated Americans have" exact="hepatitis" post="C virus (HCV) infection—and many are unaware of their"/>
 <result pre="Despite high rates of addiction-associated and injection drug use (IDU)-associated" exact="infectious diseases," post="only 11% of incarcerated people receive any addiction treatment"/>
 <result pre="to as &quot;prison�?) [2]. Many people receiving evidence-based medications for" exact="opioid use disorder" post="(MOUD) and HIV antiretroviral therapy (ART) have these discontinued"/>
 <result pre="as &quot;prison�?) [2]. Many people receiving evidence-based medications for opioid" exact="use disorder" post="(MOUD) and HIV antiretroviral therapy (ART) have these discontinued"/>
 <result pre="contribute to riskier drug use, like sharing/reusing syringes [5]. Together," exact="chronic" post="viral infections, untreated SUD, and syringe sharing among incarcerated"/>
 <result pre="to riskier drug use, like sharing/reusing syringes [5]. Together, chronic" exact="viral" post="infections, untreated SUD, and syringe sharing among incarcerated people"/>
 <result pre="among incarcerated people coalesce to drive the substance use and" exact="infectious disease" post="syndemic; in US prisons, harm reduction is an essential"/>
 <result pre="incarcerated people coalesce to drive the substance use and infectious" exact="disease" post="syndemic; in US prisons, harm reduction is an essential"/>
 <result pre="SEP began in Switzerland and quickly decreased transmission of HIV," exact="hepatitis" post="B, and hepatitis C. Prison-based SEPs have since been"/>
 <result pre="Switzerland and quickly decreased transmission of HIV, hepatitis B, and" exact="hepatitis" post="C. Prison-based SEPs have since been initiated in &amp;gt;60"/>
 <result pre="Africa, Iran, and Indonesia, prisons widely offer condoms, lubricant, and" exact="dental" post="dams to reduce the risk of HIV/HCV sexual transmission;"/>
 <result pre="harm reduction, even outside the prison system, is limited. North" exact="American" post="Syringe Exchange Network data show seven states have no"/>
 <result pre="injection equipment. In US prisons, there are no SEPs and" exact="limited" post="access to MOUD and condoms, leaving thousands of incarcerated"/>
 <result pre="Basic Principles for the Treatment of Prisoners, WHO Guidelines on" exact="HIV/AIDS" post="in Prisons, and International Guidelines on HIV/AIDS and Human"/>
 <result pre="WHO Guidelines on HIV/AIDS in Prisons, and International Guidelines on" exact="HIV/AIDS" post="and Human Rights [7]. Moreover, at a domestic level,"/>
 <result pre="been reported; instead, prison staff report feeling more protected from" exact="infection" post="after the institution of SEPs [6]. Furthermore, every dollar"/>
 <result pre="and every dollar spent on MOUD can return $12 in" exact="total" post="savings, accounting for both the cost of drug-related crime"/>
 <result pre="care. Implementing SEPs and offering treatment for HIV, HCV, and" exact="substance use disorder" post="in prison is important from a public health perspective"/>
 <result pre="Implementing SEPs and offering treatment for HIV, HCV, and substance" exact="use disorder" post="in prison is important from a public health perspective"/>
 <result pre="prison is important from a public health perspective to reduce" exact="infectious diseases" post="and lower SUD-related morbidity and mortality. It is likewise"/>
 <result pre="from a public health perspective to reduce infectious diseases and" exact="lower" post="SUD-related morbidity and mortality. It is likewise critical from"/>
 <result pre="Justice Programs; 2016. [Accessed 2/13/2020 at https://www.bjs.gov/index.cfm?ty=kfdetail&amp;amp;iid=493]. 2CalifanoJ.JrBehind bars II:" exact="substance abuse" post="and America's prison population2010National Center on Addiction and Substance"/>
 <result pre="in prisons, 2001–20102012Bureau of Justice StatisticsWashington, DCNCJ. 2016;238877(5) 4Centers for" exact="Disease" post="Control and Prevention. Hepatitis C and Incarceration. Publication No."/>
 <result pre="Justice StatisticsWashington, DCNCJ. 2016;238877(5) 4Centers for Disease Control and Prevention." exact="Hepatitis" post="C and Incarceration. Publication No. 21-1306. Centers for Disease"/>
 <result pre="Prevention. Hepatitis C and Incarceration. Publication No. 21-1306. Centers for" exact="Disease" post="Control and Prevention Website; 2013. 5JürgensR.NowakM.DayM.HIV and incarceration: prisons"/>
 <result pre="(WHO), United Nations Office on Drugs and Crime (UNODC) and" exact="Joint" post="United Nations Programme on HIV/AIDS (UNAIDS) WHO PressGeneva 7SanderG.LinesR.HIV,"/>
 <result pre="Drugs and Crime (UNODC) and Joint United Nations Programme on" exact="HIV/AIDS" post="(UNAIDS) WHO PressGeneva 7SanderG.LinesR.HIV, Hepatitis C, TB, harm reduction,"/>
 <result pre="Joint United Nations Programme on HIV/AIDS (UNAIDS) WHO PressGeneva 7SanderG.LinesR.HIV," exact="Hepatitis" post="C, TB, harm reduction, and persons deprived of liberty:"/>
 <result pre="Substitution maintenance therapy in the management of opioid dependence and" exact="HIV/AIDS" post="prevention; 2004."/>
</results>
